-

ConcertAI’s TeraRecon and 3DR Labs Announce Expanded Partnership to Transform the Delivery of AI-Enabled Image Post Processing Clinical Services for US Healthcare Providers

Cloud-based, innovative, AI-powered technologies enable the streamlined delivery of leading clinical services and scaled operations in advanced Imaging

CAMBRIDGE, Mass. & LOUISVILLE, Ky.--(BUSINESS WIRE)--ConcertAI's TeraRecon, a leader in integrating advanced imaging workflows with clinical AI, has announced an expanded partnership with 3DR® Labs, a leading provider of 3D medical image post-processing and clinically integrated AI services in the United States. This collaboration aims to enhance clinical service delivery for advanced imaging by expanding the range of domain-specific workflows and clinical AI technologies. As a result, it will benefit numerous hospitals across the country.

The foundation of this partnership is TeraRecon's new TRSubscription™ offering, which grants 3DR Labs access to a comprehensive suite of advanced visualization tools, AI-powered clinical applications, and cloud services, all under a unified model. By integrating clinical AI and cloud technologies, both companies aim to equip healthcare providers with the latest innovations in imaging diagnostics and surgical planning. Additionally, TeraRecon will become a founding member of 3DR's AI Labs, a vendor-agnostic services platform designed for universal workflow integration using AI.

“Our partnership with 3DR addresses critical industry challenges, including increased pressure on hospital resources, rising demand for complex imaging analysis services, and the need for practical AI applications with validated clinical benefits,” said Dhiraj Carumbaya, SVP & GM for ConcertAI’s TeraRecon business. “Our new technology subscription gives customers full access to a range of clinical applications to comprehensively deliver exceptional service across their imaging enterprise.”

The partnership will help transition 3DR's clinical operations to the Cloud, an integral component of the TRSubscription™. This migration will streamline the interaction between 3DR Labs and its hospital clients by enabling secure, cloud-based data transmission and remote visualization capabilities, enhancing 3DR Labs' ability to scale its services while maintaining the highest clinical quality and data security standards.

“As demand for advanced medical imaging analysis continues to grow, this partnership allows 3DR Labs to stay at the forefront of innovation,” said Mike Jackman, CEO of 3DR Labs. “High-quality, outsourced 3D medical imaging services and AI-enabled insights enhance our ability to serve our hospital partners efficiently. By leveraging TeraRecon’s technology and partnering to offer AI as-a-service, we can scale our operations to meet increasing clinical needs while maintaining our commitment to exceptional quality and service.”

TeraRecon's new TRSubscription™ introduces cutting-edge advancements in AI for image processing technologies and clinical workflows throughout the imaging enterprise. This solution enables 3DR Labs to reinforce its leadership in offering clinical services for medical imaging post-processing and innovative surgical planning for hospitals. Visit TeraRecon at ACC2025, booth 17009, to learn more.

About ConcertAI

ConcertAI is the leader in predictive and generative AI SaaS and real-world data research solutions for healthcare and life sciences. Our mission is to accelerate insights and outcomes for patients through research-ready data, CARAai™ technologies, and scientific expertise in partnership with over 46 leading biomedical innovators, 2,000 healthcare providers, and medical societies. TeraRecon provides advanced radiological image visualizations and clinical AI decision augmentation solutions for MRI and CT. CancerLinQ® is an initiative of ConcertAI, providing oncology providers with ASCO-aligned automated QOPI and ASCO Certified® quality solutions and SmartLinQ™ analytic services. Headquartered in Cambridge, MA, ConcertAI has offices in Bangalore, Frankfurt, Philadelphia, Raleigh-Durham, and Tokyo. For more information, visit us at concertai.com.

About 3DR Labs

Headquartered in Louisville, Kentucky, 3DR Labs, LLC provides round-the-clock access to more than 250 expert radiologic technologists, cutting-edge imaging software, and advanced clinical AI workflow solutions. 3DR’s AI Labs, a vendor-agnostic services platform, connects imaging departments to a gateway of 3D workflow automation, delivering quality, speed, and efficiency within medical imaging systems. Founded in 2005, 3DR Labs provides services to over a thousand hospital imaging departments, stand-alone imaging centers, and radiology practices. Turnaround times for CT and MRI exams are guaranteed within hours or even minutes. For more information, please visit https://3drlabs.com/.

Contacts

ConcertAI


Release Versions

Contacts

Social Media Profiles
More News From ConcertAI

ConcertAI Provides Intelligent Automation of ASCO® Guidelines into its Generative and Agentic AI Precision Suite™ and CancerLinQ® SmartLinQ™ Solutions

CAMBRIDGE, Mass.--(BUSINESS WIRE)--ConcertAI, a leader in oncology generative and agentic AI SaaS and multi-modal data (MMD) solutions for healthcare and life sciences, today announced the integration of the American Society of Clinical Oncology® (ASCO®) Guidelines through the CARAai platform for its Precision Suite and CancerLinQ® SmartLinQ solutions™. Now, the power of the Precision Suite’s low-latency and high-recency data can be used by biopharma researchers to assess Guideline-concordant c...

ConcertAI Launches New Generative and Agentic AI-Powered Precision Suite™ Accelerating Oncology Insights and Actions for Healthcare and Life Sciences

CAMBRIDGE, Mass.--(BUSINESS WIRE)--ConcertAI, a leader in oncology-focused generative and agentic AI solutions, today announced the launch of its new Precision Suite™. This groundbreaking family of AI-powered solutions redefines the way life sciences and healthcare organizations achieve actionable insights, optimize clinical trials, accelerate in-market execution, and drive improved patient outcomes while saving millions in cost. Powered by ConcertAI's proprietary CARAai™ platform and the unpar...

ConcertAI Announces Leadership Transition to Accelerate AI Innovation and Growth

CAMBRIDGE, Mass.--(BUSINESS WIRE)--ConcertAI, a leader in oncology generative and agentic AI SaaS and multi-modal data solutions for healthcare and life sciences, announced today that Eron Kelly has been appointed Chief Executive Officer. Kelly succeeds Dr. Jeff Elton, who will transition from his role as CEO to Vice Chairman of the company. Kelly comes to ConcertAI from Inovalon, a cloud-based healthcare SaaS provider, where he has served as President since 2021. During his tenure at Inovalon,...
Back to Newsroom